12:04 PM EDT, 03/24/2026 (MT Newswires) -- Tenax Therapeutics ( TENX ) filed a registration statement Tuesday for the sale of up to $300 million of securities from time to time.
The filing covers common and preferred stocks, debt securities, warrants, units, and rights.
Net proceeds will be used for general corporate purposes.
Price: 13.66, Change: -0.61, Percent Change: -4.27